Felice A. Janser
Bern, BE 3008, Switzerland
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 8 publications
Corrigendum to "Chaperone-Mediated Autophagy Markers LAMP2A and HSC70 Are Independent Adverse Prognostic Markers in Primary Resected Squamous Cell Carcinomas of the Lung".
Journal: Oxidative medicine and cellular longevity
Published: November 10, 2021
Increased LAMP2A levels correlate with a shorter disease-free survival of HER2 negative breast cancer patients and increased breast cancer cell viability.
Journal: Biochemical and biophysical research communications
Published: June 05, 2021
Chaperone-Mediated Autophagy Markers LAMP2A and HSC70 Are Independent Adverse Prognostic Markers in Primary Resected Squamous Cell Carcinomas of the Lung.
Journal: Oxidative medicine and cellular longevity
Published: March 20, 2020
Correction: A specific expression profile of LC3B and p62 is associated with nonresponse to neoadjuvant chemotherapy in esophageal adenocarcinomas.
Journal: PloS one
Published: October 31, 2019
The role of autophagy in HER2-targeted therapy.
Journal: Swiss medical weekly
Published: October 28, 2019
Her2-Targeted Therapy Induces Autophagy in Esophageal Adenocarcinoma Cells.
Journal: International journal of molecular sciences
Published: September 15, 2018
A specific expression profile of LC3B and p62 is associated with nonresponse to neoadjuvant chemotherapy in esophageal adenocarcinomas.
Journal: PloS one
Published: August 23, 2017
Showing 1-8 of 8
Last Updated: 09/26/2026